Publications

Journal Article
Research Support, Non-U.S. Gov't
Ppublish 54 citations
Electronic publication date
June 3, 2014

View on Pubmed.gov 24366254 | View on doi.org 10.1128/IAI.014...

The Nod1, Nod2, and Rip2 axis contributes to host immune defense against intracellular Acinetobacter baumannii infection.

Search for publications in this journal Infect Immun - 82(3):1112-22

Abstract

Acinetobacter baumannii is a major extensively drug-resistant lethal human nosocomial bacterium. However, the host innate immune mechanisms controlling A. baumannii are not well understood. Although viewed as an extracellular pathogen, A. baumannii can also invade and survive intracellularly. However, whether host innate immune pathways sensing intracellular bacteria contribute to immunity against A. baumannii is not known. Here, we provide evidence for the first time that intracellular antibacterial innate immune receptors Nod1 and Nod2, and their adaptor Rip2, play critical roles in the sensing and clearance of A. baumannii by human airway epithelial cells in vitro. A. baumannii infection upregulated Rip2 expression. Silencing of Nod1, Nod2, and Rip2 expression profoundly increased intracellular invasion and prolonged the multiplication and survival of A. baumannii in lung epithelial cells. Notably, the Nod1/2-Rip2 axis did not contribute to the control of A. baumannii infection of human macrophages, indicating that they play cell type-specific roles. The Nod1/2-Rip2 axis was needed for A. baumannii infection-induced activation of NF-κB but not mitogen-activated protein kinases. Moreover, the Nod1/2-Rip2 axis was critical to induce optimal cytokine and chemokine responses to A. baumannii infection. Mechanistic studies showed that the Nod1/2 pathway contributed to the innate control of A. baumannii infection through the production of β-defensin 2 by airway epithelial cells. This study revealed new insights into the immune control of A. baumannii and may contribute to the development of effective immune therapeutics and vaccines against A. baumannii.

References

Clin Infect Dis. 2006 Mar 1;42(5):657-68

J Leukoc Biol. 2010 Dec;88(6):1207-16

Annu Rev Microbiol. 2010;64:203-21

Infect Immun. 2009 Mar;77(3):1015-21

Cited by 54 citations (total)

Journal Article Research Support, N.I.H., Extramural

Modern Acinetobacter baumannii clinical isolates replicate inside spacious vacuoles and egress from macrophages.

Electronic publication date December 1, 2021

Search for publications in this journal PLoS Pathog

Gabriela Sycz [...] Mario F Feldman et al.

Multidrug-resistant Acinetobacter baumannii infections are increasing at alarming rates. Therefore, novel antibiotic-sparing treatments to combat these A. baumannii infections are...

Journal Article Review Research Support, N.I.H., Extramural

Role of toll-like receptors and nod-like receptors in acute lung infection.

Electronic publication date September 5, 2023

Search for publications in this journal Front Immunol

John Le [...] Samithamby Jeyaseelan et al.

The respiratory system exposed to microorganisms continuously, and the pathogenicity of these microbes not only contingent on their virulence factors,...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances